Nitric Oxide-mediated Neurotransmission is Attenuated in the Anococcygeus Muscle from Diabetic Rats

Overview

Journal Diabetologia

Specialty Endocrinology

Date 1994 Mar 1

PMID 8174835

Citations 4

Authors

K J Way

J J REID

Affiliations

Soon will be listed here.

Abstract

The effect of STZ-induced diabetes of 8-weeks duration was examined on nitric oxide-mediated neurotransmission in the rat anococcygeus muscle. In the presence of noradrenergic blockade and raised tissue tone, relaxant response to nerve stimulation (0.5-5 Hz, for 10 s), sodium nitroprusside (5 and 10 nmol/l) and nitric oxide (1 and 3 mumol/l) were significantly reduced in anococcygeus muscles from diabetic rats compared to responses from control rats (p < 0.05). In contrast, relaxations to papaverine (3 and 10 mumol/l) were not reduced in tissues from diabetic rats. The nitric oxide synthesis inhibitor NOLA (100 mumol/l) abolished relaxant responses to nerve stimulation but had no effect on responses to any of the relaxant agents used. Exposure to NOLA at 10 mumol/l reduced stimulation-induced relaxations; this reduction was significantly greater in tissues from the diabetic group than from the control group (p < 0.05), probably as a consequence of the smaller relaxant responses in muscles from diabetic rats. Contractile responses to nerve stimulation (1-10 Hz, for 10 s), but not noradrenaline (0.03-30 mumol/l), were significantly greater in anococcygeus muscles from diabetic rats than from control rats (p < 0.05). NOLA (100 mumol/l) significantly enhanced stimulation-induced contractions (p < 0.05), however the enhancement was significantly less in tissues from diabetic rats (p < 0.05). The results suggest that STZ-induced diabetes impairs smooth muscle reactivity to nitric oxide in the rat anococcygeus muscle.

Citing Articles

Nitric oxide synthase (NOS) expression in the myenteric plexus of streptozotocin-diabetic rats.

Wrzos H, Cruz A, Polavarapu R, Shearer D, Ouyang A Dig Dis Sci. 1997; 42(10):2106-10.

PMID: 9365143 DOI: 10.1023/a:1018830820537.

Effect of diabetes on relaxations to non-adrenergic, non-cholinergic nerve stimulation in longitudinal muscle of the rat gastric fundus.

Jenkinson K, REID J Br J Pharmacol. 1995; 116(1):1551-6.

PMID: 8564218 PMC: 1908900. DOI: 10.1111/j.1476-5381.1995.tb16372.x.

Effect of diabetes and elevated glucose on nitric oxide-mediated neurotransmission in rat anococcygeus muscle.

Way K, REID J Br J Pharmacol. 1995; 115(3):409-14.

PMID: 7582450 PMC: 1908417. DOI: 10.1111/j.1476-5381.1995.tb16348.x.

Impairment of nitrergic-mediated relaxation of rat isolated duodenum by experimental diabetes.

Massuda H, Whittle B, Moncada S Br J Pharmacol. 1995; 114(5):919-24.

PMID: 7540094 PMC: 1510331. DOI: 10.1111/j.1476-5381.1995.tb13291.x.

References

Lincoln J, Bokor J, Crowe R, Griffith S, Haven A, Burnstock G . Myenteric plexus in streptozotocin-treated rats. Neurochemical and histochemical evidence for diabetic neuropathy in the gut. Gastroenterology. 1984; 86(4):654-61. View

Vlassara H, Fuh H, Makita Z, Krungkrai S, Cerami A, Bucala R . Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications. Proc Natl Acad Sci U S A. 1992; 89(24):12043-7. PMC: 50694. DOI: 10.1073/pnas.89.24.12043. View

Oyama Y, Kawasaki H, Hattori Y, Kanno M . Attenuation of endothelium-dependent relaxation in aorta from diabetic rats. Eur J Pharmacol. 1986; 132(1):75-8. DOI: 10.1016/0014-2999(86)90013-0. View

Hosking D, Bennett T, Hampton J . Diabetic autonomic neuropathy. Diabetes. 1978; 27(10):1043-55. DOI: 10.2337/diab.27.10.1043. View

Rand M . Nitrergic transmission: nitric oxide as a mediator of non-adrenergic, non-cholinergic neuro-effector transmission. Clin Exp Pharmacol Physiol. 1992; 19(3):147-69. DOI: 10.1111/j.1440-1681.1992.tb00433.x. View

MacLeod K, McNeill J . The influence of chronic experimental diabetes on contractile responses of rat isolated blood vessels. Can J Physiol Pharmacol. 1985; 63(1):52-7. DOI: 10.1139/y85-009. View

Belai A, Lincoln J, Milner P, Burnstock G . Progressive changes in adrenergic, serotonergic, and peptidergic nerves in proximal colon of streptozotocin-diabetic rats. Gastroenterology. 1988; 95(5):1234-41. DOI: 10.1016/0016-5085(88)90356-3. View

Taylor P, McCarthy A, Thomas C, Poston L . Endothelium-dependent relaxation and noradrenaline sensitivity in mesenteric resistance arteries of streptozotocin-induced diabetic rats. Br J Pharmacol. 1992; 107(2):393-9. PMC: 1907852. DOI: 10.1111/j.1476-5381.1992.tb12757.x. View

Belai A, Lincoln J, Burnstock G . Lack of release of vasoactive intestinal polypeptide and calcitonin gene-related peptide during electrical stimulation of enteric nerves in streptozotocin-diabetic rats. Gastroenterology. 1987; 93(5):1034-40. DOI: 10.1016/0016-5085(87)90567-1. View

10.

Damato M, Curro D . Non-adrenergic non-cholinergic inhibitory innervation of the gastric fundus in streptozotocin-diabetic rats. Acta Physiol Hung. 1990; 75 Suppl:77-8. View

11.

Longhurst P, Belis J . Abnormalities of rat bladder contractility in streptozotocin-induced diabetes mellitus. J Pharmacol Exp Ther. 1986; 238(3):773-7. View

12.

Nowak T, Harrington B, Kalbfleisch J . Adaptation of cholinergic enteric neuromuscular transmission in diabetic rat small intestine. Diabetes. 1990; 39(8):891-7. DOI: 10.2337/diab.39.8.891. View

13.

Belai A, Lefebvre R, Burnstock G . Motor activity and neurotransmitter release in the gastric fundus of streptozotocin-diabetic rats. Eur J Pharmacol. 1991; 194(2-3):225-34. DOI: 10.1016/0014-2999(91)90109-4. View

14.

Rajfer J, Aronson W, Bush P, Dorey F, Ignarro L . Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med. 1992; 326(2):90-4. DOI: 10.1056/NEJM199201093260203. View

15.

Li C, Rand M . Nitric oxide and vasoactive intestinal polypeptide mediate non-adrenergic, non-cholinergic inhibitory transmission to smooth muscle of the rat gastric fundus. Eur J Pharmacol. 1990; 191(3):303-9. DOI: 10.1016/0014-2999(90)94162-q. View

16.

Belai A, Lincoln J, Milner P, Crowe R, Loesch A, Burnstock G . Enteric nerves in diabetic rats: increase in vasoactive intestinal polypeptide but not substance P. Gastroenterology. 1985; 89(5):967-76. DOI: 10.1016/0016-5085(85)90195-7. View

17.

Luheshi G, Zar M . Effect of streptozotocin diabetes on motor and inhibitory transmission in rat anococcygeus. Can J Physiol Pharmacol. 1992; 70(10):1372-8. DOI: 10.1139/y92-192. View

18.

Longhurst P . The effects of testosterone or insulin treatment on contractile responses of the rat vas deferens following castration or streptozotocin-induced diabetes mellitus. Gen Pharmacol. 1990; 21(4):427-34. DOI: 10.1016/0306-3623(90)90693-g. View

19.

Li C, Rand M . Evidence for a role of nitric oxide in the neurotransmitter system mediating relaxation of the rat anococcygeus muscle. Clin Exp Pharmacol Physiol. 1989; 16(12):933-8. DOI: 10.1111/j.1440-1681.1989.tb02404.x. View

20.

Nowak T, Harrington B, Kalbfleisch J, Amatruda J . Evidence for abnormal cholinergic neuromuscular transmission in diabetic rat small intestine. Gastroenterology. 1986; 91(1):124-32. DOI: 10.1016/0016-5085(86)90448-8. View